FDA Clears Everolimus Tablets for Seizures in Tuberous Sclerosis FDA Clears Everolimus Tablets for Seizures in Tuberous Sclerosis

Everolimus tablets for oral suspension become the first approved therapy specifically indicated for the treatment of partial-onset seizures associated with tuberous sclerosis complex.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Alert Source Type: news